Lung Cancer Risk in Rheumatoid Arthritis: An Update
The relationship between lung cancer and rheumatoid arthritis remains an active topic of research, as more information is needed regarding their association.
All articles by Jasenka Piljac Zegarac, PhD
Clinical Safety Monitoring in RA Clinical Trials: Important Considerations
It is important to take into consideration the epidemiology of RA-associated risks when interpreting safety data of clinical trials.
Insights Into TNF Antagonism in Rheumatoid Arthritis
Steven C. Vlad, MD, PhD, rheumatologist at Tufts Medical Center and assistant professor of medicine at Tufts University School of Medicine, discusses the benefits and challenges of using TNF-α inhibitors to treat rheumatoid arthritis.
Nanotherapies for Rheumatoid Arthritis: Advantages, Challenges, and Future Direction
Christine Pham, MD, chief of the Division of Rheumatology at the Washington University School of Medicine in St Louis discusses the advantages and challenges of applying nanotherapies in rheumatoid arthritis.
Inflammatory Arthritis and the Gut Microbiome: Do Microbes Hold the Key to New Treatments?
Recent research points to an association between the gut microbiome composition and various types of immune-mediated inflammatory arthritides.
Osteoarthritis Prevention: Important Considerations for Population-Based Strategies
David T. Felson, MD, MPH, and Jos Runhaar, PhD, reflect on important population-based osteoarthritis prevention strategies and knowledge gaps that still exist in this field.
Expert Q&A: A Clinical Update on the Prevention, Treatment of Periprosthetic Joint Infections
Alberto V. Carli, MD, and Ashley E. Levack, MD, MAS, discuss preventive and treatment options for periprosthetic joint infections.
Expert Insight: A Closer Look at Neurological Manifestations of Sjogren Syndrome
Experts discuss the symptoms and prevalence of neurological manifestations in Sjogren syndrome.
The Gut Microbiome and Rheumatoid Arthritis: Understanding the Connection
A better understanding of gut microbiota and metabolites produced by them may help to predict the course and heterogeneity of rheumatoid arthritis.
Neonatal Lupus: Clinical Manifestations and Treatment Options
Neonatal systemic lupus erythematosus syndrome develops as a result of passively acquired autoimmunity, when autoantibodies produced by the mother cross the placenta, affecting the developing fetus.
-
Loading...
-
Loading...
Next post in Systemic Lupus Erythematosus
